ArticleHepatology (Baltimore, Md.)2018

Use of the CRISPR/Cas9-based epigenetic gene activation system In Vivo: A new potential therapeutic modality.

Samar H Ibrahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.